Arno Therapeutics, Inc Debt Instrument, Convertible, Beneficial Conversion Feature
Arno Therapeutics, Inc reported Debt Instrument, Convertible, Beneficial Conversion Feature of $7.55 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2015-03-31
- Arno Therapeutics, Inc debt instrument, convertible, beneficial conversion feature for fiscal 2014 was $7.55M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2014-12-31 | $7.55M 10-K · filed 2015-03-31 |